FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome
T. Brevini, M. Maes, G. J. Webb…·F. Sampaziotis
This study shows FXR inhibition lowers ACE2 expression, reduces SARS-CoV-2 infection, and correlates with better clinical outcomes in COVID-19.